Congo-Kinshasa: Two Scientists On Their Race to Make a New Ebola Vaccine
Scientists are working to develop a new vaccine for the Bundibugyo strain of Ebola, which is currently causing an outbreak in the Democratic Republic of Congo. Existing vaccines only target the Zaire strain, leaving a critical gap in medical response for the current crisis.
Why it matters
Developing strain-specific vaccines is essential for controlling outbreaks in regions where conflict and poor infrastructure complicate public health efforts.
As health workers in the Democratic Republic of Congo (DRC) continue to battle an ongoing Ebola outbreak, scientists around the world are racing to develop a vaccine against the strain of the virus that's causing it.
The report is a straightforward medical news update focused on scientific progress and public health data.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in